1,032
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma: the devil is in the details

, & ORCID Icon
Article: 2278823 | Received 28 Jul 2023, Accepted 16 Oct 2023, Published online: 08 Nov 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660.
  • Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022;33(1):27–63. doi:10.1007/s12022-022-09707-3.
  • Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34. doi:10.1089/thy.2013.0367.
  • Sugitani I, Ito Y, Takeuchi D, et al. Indications and strategy for active surveillance of adult Low-Risk papillary thyroid microcarcinoma: consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma. Thyroid. 2021;31(2):183–192. doi:10.1089/thy.2020.0330.
  • Xu D, Ge M, Yang A, et al. Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors (2019 edition). J Can Res Ther. 2020;16(5):960–966. doi:10.4103/jcrt.JCRT_558_19.
  • Mauri G, Hegedus L, Bandula S, et al. European thyroid association and cardiovascular and interventional radiological society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10(3):185–197. doi:10.1159/000516469.
  • Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892–899. doi:10.1148/radiol.11110206.
  • Zhou J, Yin L, Wei X, et al. 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine. 2020;70(2):256–279. doi:10.1007/s12020-020-02441-y.
  • Russ G, Bonnema SJ, Erdogan MF, et al. European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 2017;6(5):225–237. doi:10.1159/000478927.
  • Shin JH, Baek JH, Chung J, et al. Ultrasonography diagnosis and Imaging-Based management of thyroid nodules: revised Korean society of thyroid radiology consensus statement and recommendations. Korean J Radiol. 2016;17(3):370–395. doi:10.3348/kjr.2016.17.3.370.
  • Ali SZ, Baloch ZW, Cochand-Priollet B, et al. The 2023 Bethesda system for reporting thyroid cytopathology. J Am Soc Cytopathol. 2023;12(5):319–325. doi:10.1016/j.jasc.2023.05.005.
  • Fnais N, Soobiah C, Al-Qahtani K, et al. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis. Hum Pathol. 2015;46(10):1443–1454. doi:10.1016/j.humpath.2015.06.001.
  • Romei C, Elisei R. A narrative review of genetic alterations in primary thyroid epithelial cancer. Int J Mol Sci. 2021;22(4):1726. doi:10.3390/ijms22041726.
  • Lin KL, Wang OC, Zhang XH, et al. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann Surg Oncol. 2010;17(12):3294–3300. doi:10.1245/s10434-010-1129-6.
  • Zheng X, Wei S, Han Y, et al. Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases. Ann Surg Oncol. 2013;20(7):2266–2273. doi:10.1245/s10434-012-2851-z.
  • Lin Y, Wu ZR, Shi YP, et al. Radiofrequency ablation of unifocal papillary thyroid microcarcinoma with BRAF V600E mutation. J Clin Endocrinol Metab. 2023;108(11):e1298–e1305. doi:10.1210/clinem/dgad269.
  • Attia AS, Hussein M, Issa PP, et al. Association of BRAF(V600E) mutation with the aggressive behavior of papillary thyroid microcarcinoma: a Meta-Analysis of 33 studies. Int J Mol Sci. 2022;23(24):15626. doi:10.3390/ijms232415626.
  • Lan L, Luo Y, Zhou M, et al. Comparison of diagnostic accuracy of thyroid cancer with ultrasound-guided fine-needle aspiration and core-needle biopsy: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020;11:44. doi:10.3389/fendo.2020.00044.
  • Zhang L, Wei WJ, Ji QH, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012;97(4):1250–1257. doi:10.1210/jc.2011-1546.
  • Cai J, Fang F, Chen J, et al. Unilateral multifocality and bilaterality could be two different multifocal entities in patients with papillary thyroid microcarcinoma. Biomed Res Int. 2020;2020:9854964.
  • Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: a meta-analysis. Int J Surg. 2018;50:121–125. doi:10.1016/j.ijsu.2017.12.035.
  • Nagaoka R, Ebina A, Toda K, et al. Multifocality and progression of papillary thyroid microcarcinoma during active surveillance. World J Surg. 2021;45(9):2769–2776. doi:10.1007/s00268-021-06185-2.
  • Yan L, Zhen Y, Li Y, et al. Five-year outcome between radiofrequency ablation vs. Surgery for unilateral multifocal papillary thyroid microcarcinoma. J Clin Endocrinol Metab. 2023;15:dgad360. doi:10.1210/clinem/dgad360.
  • Yu XY, Zhou HD, Wei Y, et al. Preliminary study of microwave ablation for multifocal papillary thyroid microcarcinoma in nonoperative candidates. J Vasc Interv Radiol. 2023;34(6):999–1006. doi:10.1016/j.jvir.2023.01.035.
  • Chai YJ, Kim SJ, Choi JY, et al. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis. World J Surg. 2014;38(6):1306–1311. doi:10.1007/s00268-013-2406-x.
  • Luo H, Yan F, Lan L, et al. Ultrasonographic features, nodule size, capsular invasion, and lymph node metastasis of solitary papillary carcinoma of thyroid isthmus. Front Oncol. 2020;10:558363. doi:10.3389/fonc.2020.558363.
  • Karatzas T, Charitoudis G, Vasileiadis D, et al. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: a case control study. Int J Surg. 2015;18:64–68. doi:10.1016/j.ijsu.2015.04.039.
  • Zheng L, Liu FY, Yu J, et al. Thermal ablation for papillary thyroid microcarcinoma located in the isthmus: a study with 3 years of follow-up. Future Oncol. 2022;18(4):471–480. doi:10.2217/fon-2021-0463.
  • Zheng L, Dou JP, Han ZY, et al. Microwave ablation for papillary thyroid microcarcinoma with and without US-detected capsule invasion: a multicenter prospective cohort study. Radiology. 2023;307(3):e220661. doi:10.1148/radiol.220661.
  • Wang Y, Nie F, Wang G, et al. Value of combining clinical factors, conventional ultrasound, and Contrast-Enhanced ultrasound features in preoperative prediction of Central lymph node metastases of different sized papillary thyroid carcinomas. Cancer Manag Res. 2021;13:3403–3415. doi:10.2147/CMAR.S299157.
  • Xing Z, Qiu Y, Yang Q, et al. Thyroid cancer neck lymph nodes metastasis: meta-analysis of US and CT diagnosis. Eur J Radiol. 2020;129:109103. doi:10.1016/j.ejrad.2020.109103.
  • Baek JH, Cho SJ. Thermal ablation for small papillary thyroid cancer: a potential game changer. Radiology. 2021;300(1):217–218. doi:10.1148/radiol.2021210424.
  • Rhee CM, Bhan I, Alexander EK, et al. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med. 2012;172(2):153–159. doi:10.1001/archinternmed.2011.677.
  • Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2020;67(1):35–43. doi:10.1007/s12020-019-02019-3.
  • Ren Y, Han X, Li Y, et al. Initial ablation ratio predicting the recurrence of low-risk papillary thyroid microcarcinomas treated with microwave ablation: a 5-year, single-institution cohort study. Endocr Connect. 2023;12(9):e230128. doi:10.1530/EC-23-0128.
  • Bednarczuk T, Brix TH, Schima W, et al. 2021 European thyroid association guidelines for the management of iodine-based contrast media-induced thyroid dysfunction. Eur Thyroid J. 2021;10(4):269–284. doi:10.1159/000517175.
  • Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and Meta-Analysis. Thyroid. 2020;30(5):720–731. doi:10.1089/thy.2019.0707.
  • Orloff LA, Noel JE, Stack BC, Jr., et al. Radiofrequency ablation and related ultrasound‐guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head Neck. 2022;44(3):633–660. doi:10.1002/hed.26960.
  • Teng DK, Li WH, Du JR, et al. Effects of microwave ablation on papillary thyroid microcarcinoma: a five-year follow-up report. Thyroid. 2020;30(12):1752–1758. doi:10.1089/thy.2020.0049.
  • Song Q, Gao H, Ren L, et al. Radiofrequency ablation versus total thyroidectomy in patients with papillary thyroid microcarcinoma located in the isthmus: a retrospective cohort study. Int J Hyperthermia. 2021;38(1):708–714. doi:10.1080/02656736.2021.1916625.
  • Tuttle RM, Li D, Ridouani F. Percutaneous ablation of low-risk papillary thyroid cancer. Endocr Relat Cancer. 2023;30(3):e220244. doi:10.1530/ERC-22-0244.
  • Wu J, Zhao ZL, Cao XJ, et al. A feasibility study of microwave ablation for papillary thyroid cancer close to the thyroid capsule. Int J Hyperthermia. 2021;38(1):1217–1224. doi:10.1080/02656736.2021.1962549.
  • Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655. doi:10.3348/kjr.2018.19.4.632.
  • Yan L, Zhang M, Song Q, et al. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study. Eur Radiol. 2022;32(2):1216–1226. doi:10.1007/s00330-021-08133-z.
  • Chung SR, Baek JH, Choi YJ, et al. Thermal ablation for the management of papillary thyroid microcarcinoma in the era of active surveillance and hemithyroidectomy. Curr Oncol Rep. 2022;24(8):1045–1052. doi:10.1007/s11912-022-01268-2.
  • Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):1278–1286.
  • Yan L, Li Y, Li XY, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: a retrospective study with more than 5 years of follow-up. Cancer. 2023;129(16):2469–2478. doi:10.1002/cncr.34802.
  • Yan L, Zhang M, Song Q, et al. Ultrasound-guided radiofrequency ablation versus thyroid lobectomy for low-risk papillary thyroid microcarcinoma: a propensity-matched cohort study of 884 patients. Thyroid. 2021;31(11):1662–1672. doi:10.1089/thy.2021.0100.
  • Lu C, Li X, Chu X, et al. Clinical effects of microwave ablation in the treatment of low-risk papillary thyroid microcarcinomas and related histopathological changes. Front Endocrinol (Lausanne). 2021;12:751213. doi:10.3389/fendo.2021.751213.
  • Yan L, Luo Y, Zhang Y, et al. The clinical application of core-needle biopsy after radiofrequency ablation for low-risk papillary thyroid microcarcinoma: a large cohort of 202 patients study. J Cancer. 2020;11(18):5257–5263. doi:10.7150/jca.42673.
  • Sugitani I, Fujimoto Y, Yamada K. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg. 2014;38(3):673–678. doi:10.1007/s00268-013-2335-8.
  • Kim HI, Jin M, Ko NG, et al. Effect of TSH levels during active surveillance of PTMC according to age. Endocr Relat Cancer. 2022;29(4):191–200. doi:10.1530/ERC-21-0403.
  • Yamamoto M, Miyauchi A, Ito Y, et al. Active surveillance outcomes of patients with low-risk papillary thyroid microcarcinoma according to levothyroxine treatment status. Thyroid. 2023;33(10):1182–1189. doi:10.1089/thy.2023.0046.
  • Li X, Yan L, Xiao J, et al. Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation. Int J Hyperthermia. 2023;40(1):2160880.
  • Zhu Y, Che Y, Gao S, et al. Long-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study. Int J Hyperthermia. 2021;38(1):1225–1232. doi:10.1080/02656736.2021.1963850.
  • Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2021;31(2):685–694. doi:10.1007/s00330-020-07128-6.
  • Ito Y, Onoda N, Okamoto T. The revised clinical practice guidelines on the management of thyroid tumors by the Japan associations of endocrine surgeons: core questions and recommendations for treatments of thyroid cancer. Endocr J. 2020;67(7):669–717. doi:10.1507/endocrj.EJ20-0025.
  • Miyauchi A, Ito Y, Fujishima M, et al. Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience. Thyroid. 2023;33(7):817–825. doi:10.1089/thy.2023.0076.
  • Pace-Asciak P, Russell JO, Tufano RP. Review: improving quality of life in patients with differentiated thyroid cancer. Front Oncol. 2023;13:1032581. doi:10.3389/fonc.2023.1032581.
  • Li R, Li G, Wang Y, et al. Psychological distress and sleep disturbance throughout thyroid nodule screening, diagnosis, and treatment. J Clin Endocrinol Metab. 2021;106(10):e4221–e4230. doi:10.1210/clinem/dgab224.
  • Jeon MJ, Lee YM, Sung TY, et al. Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy: a cross-sectional study. Thyroid. 2019;29(7):956–962. doi:10.1089/thy.2018.0711.
  • Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol. 2018;144(4):771–779. doi:10.1007/s00432-018-2607-7.
  • Ji L, Wu Q, Gu J, et al. Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients. Cancer Imaging. 2019;19(1):16. doi:10.1186/s40644-019-0204-x.
  • Teng DK, Li HQ, Sui GQ, et al. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine. 2019;64(1):109–117. doi:10.1007/s12020-019-01868-2.
  • Lim HK, Cho SJ, Baek JH, et al. US-guided radiofrequency ablation for Low-Risk papillary thyroid microcarcinoma: efficacy and safety in a large population. Korean J Radiol. 2019;20(12):1653–1661. doi:10.3348/kjr.2019.0192.
  • Yue WW, Qi L, Wang DD, et al. US-guided microwave ablation of Low-Risk papillary thyroid microcarcinoma: longer-Term results of a prospective study. J Clin Endocrinol Metab. 2020;105(6):dgaa128. doi:10.1210/clinem/dgaa128.
  • Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. 2020;30(12):1745–1751. doi:10.1089/thy.2020.0106.
  • Wu R, Luo Y, Tang J, et al. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients. Int J Hyperthermia. 2020;37(1):168–174. doi:10.1080/02656736.2019.1708480.
  • Kim HJ, Chung SM, Kim H, et al. Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: results of a 10-year retrospective study. Thyroid. 2021;31(11):1723–1729. doi:10.1089/thy.2021.0151.
  • Cao XJ, Yu MA, Zhu YL, et al. Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma: a multicenter retrospective study. Int J Hyperthermia. 2021;38(1):916–922. doi:10.1080/02656736.2021.1936218.
  • Yan L, Zhang M, Song Q, et al. The efficacy and safety of radiofrequency ablation for bilateral papillary thyroid microcarcinoma. Front Endocrinol (Lausanne). 2021;12:663636. doi:10.3389/fendo.2021.663636.
  • Mauri G, Orsi F, Carriero S, et al. Image-Guided thermal ablation as an alternative to surgery for papillary thyroid microcarcinoma: preliminary results of an Italian experience. Front Endocrinol (Lausanne). 2020;11:575152. doi:10.3389/fendo.2020.575152.
  • Song Q, Gao H, Tian X, et al. Evaluation of ultrasound-guided radiofrequency ablation as a treatment option for papillary thyroid microcarcinoma in the isthmus: a retrospective study. Front Endocrinol (Lausanne). 2020;11:599471. doi:10.3389/fendo.2020.599471.
  • Juan Z, Yongping L, Han X, et al. A 5-year follow-up study on the efficacy and safety of ultrasound-guided laser ablation in elderly patients with papillary thyroid microcarcinoma: a retrospective, single-center study from China. Front Endocrinol (Lausanne). 2022;13:972589. doi:10.3389/fendo.2022.972589.
  • Zhang L, Zhang GP, Zhan WW, et al. The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma. Front Endocrinol (Lausanne). 2022;13:921812. doi:10.3389/fendo.2022.921812.
  • Yan L, Liu Y, Li W, et al. Long-term outcomes of ultrasound-guided thermal ablation for the treatment of solitary low-risk papillary thyroid microcarcinoma: a multicenter retrospective study. Ann Surg. 2023;277(5):846–853. doi:10.1097/SLA.0000000000005800.
  • Han ZY, Dou JP, Zheng L, et al. Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study. Eur Radiol. 2023;33(11):7942–7951. doi:10.1007/s00330-023-09802-x.